The global anal fistula treatment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The market growth is majorly attributed owing to the rising cases of inflammatory bowel diseases including ulcerative colitis and Crohn’s disease, increasing prevalence of anal fistula cases, launch of new drugs, and the increasing demand for non-surgical methods such as fibrin glue injection and adipose-derived stem cell therapy. There has been an increasing prevalence of anal fistula cases as it remains an ambiguous condition for the colorectal surgeon.
To Request a Sample of our Report on Global Anal Fistula Treatment Market: https://www.omrglobal.com/request-sample/anal-fistula-treatment-market
According to the Global Burden of Disease (GBD) 2017 Inflammatory Bowel Disease Collaborators, there were 6.8 million cases of inflammatory bowel disease reported globally. The age standardized prevalence rate increased from 79.5 per 100,000 population in 1990 to 84.3 per 100,000 population in 2017. Adding to this, there is a surge in the demand for a safe and effective treatment that has no probability of recurrence coupled with fewer side effects that are pushing the key industry players to introduce advanced drugs and devices.
Some key players operating in the market include Medtronic plc, Cook Medical, and Takeda Pharmaceutical Co., Ltd. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in February 2018, AMI has launched FiXcision instrument, which consists of the guide, circular blade, probe and base plate for the precise treatment of anal fistulas.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Treatment Type
- By Application
- By End-User
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Medtronic plc, Cook Medical, and Takeda Pharmaceutical Co., Ltd., among others.
A full Report of Global Anal Fistula Treatment Market is Available @ https://www.omrglobal.com/industry-reports/anal-fistula-treatment-market
Global Anal Fistula Treatment Market Report by Segment
By Type
- Surgical
- Non-Surgical
By Application
- Intersphincteric Fistula
- Transsphincteric Fistula
- Suprasphincteric Fistula
- Others
By End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Anal Fistula Treatment Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anal-fistula-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
